Troublesome Advertising
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
In the Oct. 10 news story "Report Faults FDA on Drug Safety," the Institute of Medicine suggested banning consumer advertising of newly approved classes of drugs until they have been on the market long enough for any problems to emerge.
It is especially troubling to see television ads for bisphosphonates such as Boniva and Fosamax. Certainly, these medications appear to be useful in treating osteoporosis, but they also appear to have serious risks in an as-yet-unknown percentage of patients. Jawbone infections known as bisphosphonate-associated osteonecrosis (BON) have serious morbidity and mortality issues and are difficult to treat. It is scandalous to allow these drugs to be advertised on television.
RONALD S. BROWN
Arlington
The writer is a professor of oral diagnosis at the Howard University College of Dentistry.
